Afficher la notice abrégée

Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase

dc.rights.licenseopenen_US
dc.contributor.authorMAILLARD, Olivier
dc.contributor.authorBUN, Rene
dc.contributor.authorLAANANI, Moussa
dc.contributor.authorVERGA-GERARD, Amandine
dc.contributor.authorLEROY, Taylor
dc.contributor.authorGAULT, Nathalie
dc.contributor.authorESTELLAT, Candice
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorNOIZE, Pernelle
dc.contributor.authorKAGUELIDOU, Florentia
dc.contributor.authorSOMMET, Agnes
dc.contributor.authorLAPEYRE-MESTRE, Maryse
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorFOURRIER-REGLAT, Annie
dc.contributor.authorWEILL, Alain
dc.contributor.authorQUANTIN, Catherine
dc.contributor.authorTUBACH, Florence
dc.date.accessioned2024-08-21T08:31:47Z
dc.date.available2024-08-21T08:31:47Z
dc.date.issued2024-05-21
dc.identifier.issn1958-5578en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201215
dc.description.abstractEnAIM OF THE STUDY: The French National Health Data System (SNDS) comprises healthcare data that cover 99% of the population (over 67 million individuals) in France. The aim of this study was to present an overview of published pharmacoepidemiological studies using the SNDS in its maturation phase. METHODS: We conducted a systematic literature review of original research articles in the Pubmed and EMBASE databases from January 2012 until August 2018. RESULTS: A total of 316 full-text articles were included, with an annual increase over the study period. Only 16 records were excluded after screening because they did not involve the SNDS but other French healthcare databases. The study design was clearly reported in only 66% of studies of which 57% were retrospective cohorts and 22% cross-sectional studies. The reported study objectives were drug utilization (65%), safety (22%) and effectiveness (9%). Almost all ATC groups were studied but the most frequent ones concerned the nervous system in 149 studies (49%), cardiovascular system drugs in 104 studies (34%) and anti-infectives for systemic use in 50 studies (16%). CONCLUSION: The SNDS is of growing interest for studies on drug use and safety, which could be conducted more in specific populations, including children, pregnant women and the elderly, as these populations are often not included in clinical trials.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enHealthcare databases
dc.subject.enPharmacoepidemiology
dc.subject.enReal world data
dc.subject.enSystematic review
dc.title.enUse of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase
dc.title.alternativeTherapiesen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2024.05.003en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38834394en_US
bordeaux.journalTherapiesen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Therapies&rft.date=2024-05-21&rft.eissn=1958-5578&rft.issn=1958-5578&rft.au=MAILLARD,%20Olivier&BUN,%20Rene&LAANANI,%20Moussa&VERGA-GERARD,%20Amandine&LEROY,%20Taylor&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_Therapie_2024_Maillard.pdf
Taille:
1.105Mo
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
811octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée